Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
22.30
+0.02 (0.09%)
Jan 23, 2026, 3:00 PM CST
SHA:603896 Market Cap
SHA:603896 has a market cap or net worth of 4.42 billion as of January 23, 2026. Its market cap has increased by 3.48% in one year.
Market Cap
4.42B
Enterprise Value
3.91B
Revenue
642.66M
Ranking
n/a
PE Ratio
32.20
Stock Price
22.30
Market Cap Chart
Since May 10, 2017, SHA:603896's market cap has increased from 2.32B to 4.42B, an increase of 90.10%. That is a compound annual growth rate of 7.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 4.42B | 14.96% |
| Dec 31, 2025 | 3.84B | -8.63% |
| Dec 31, 2024 | 4.20B | -34.21% |
| Dec 29, 2023 | 6.39B | -18.28% |
| Dec 30, 2022 | 7.82B | -11.47% |
| Dec 31, 2021 | 8.83B | 75.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovita Biological Technology | 4.77B |
| Zhejiang Wecome Pharmaceutical Company | 4.76B |
| Pulike Biological Engineering | 4.71B |
| Guanhao Biotech | 4.33B |
| Shanghai Hile Bio-Technology | 4.20B |
| Shanghai Shen Lian Biomedical | 4.18B |
| Boji Medical Technology | 4.13B |
| Shenzhen Bioeasy Biotechnology | 4.09B |